THOMPSON DAVIS & CO., INC. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 92 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$55,000
-52.6%
2,871
-66.4%
0.12%
-56.5%
Q2 2018$116,000
+34.9%
8,553
-28.5%
0.28%
+21.6%
Q1 2018$86,000
+290.9%
11,969
+102.5%
0.23%
+336.5%
Q4 2017$22,0005,9110.05%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders